Showing results (121-130 of 1,091) with videos related to
Sort By:
Pageof 110
Idrugs : the Investigational Drugs Journal|June 6, 2003
Pralnacasan (vertex pharmaceuticals)Britta Siegmund, Martin ZeitzIdrugs : the Investigational Drugs Journal|August 15, 2003
Bioterrorism: a new frontier for drug discovery and developmentKunwar ShailubhaiIdrugs : the Investigational Drugs Journal|July 16, 2003
Chloroquine and artemisinin: six decades of research--what next?Laurence Delhaes, Françoise Benoit-Vical, Daniel Camus, et al.Idrugs : the Investigational Drugs Journal|July 16, 2003
Lanthanum carbonate (Shire)Francesco Locatelli, Marco D'Amico, Giuseppe PontorieroIdrugs : the Investigational Drugs Journal|September 6, 2007
Key factors in evaluating potential clinical biomarkersMichael Spain, Ralph McDadeIdrugs : the Investigational Drugs Journal|August 1, 2007
Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitorsRegine Schneider-Stock, Matthias OckerIdrugs : the Investigational Drugs Journal|July 5, 2008
Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: challenges and feasibilityFilip K Knop, Jens J Holst, Tina VilsbøllIdrugs : the Investigational Drugs Journal|October 31, 2007
Considerations for generic oncology FDG-PET/CT protocol preparation in drug developmentWilliam A Hallett, R Paul Maguire, Timothy J McCarthy, et al.Pageof 110